Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4747075> ?p ?o }
Showing triples 1 to 31 of
31
with 100 triples per page.
- Q4747075 subject Q8252305.
- Q4747075 subject Q8918235.
- Q4747075 subject Q9536267.
- Q4747075 abstract "Exforge is the brand name of an oral blood pressure lowering medication which combines two medications in a film-coated tablet. It contains amlodipine, a dihydropyridine-type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist (ARB or A2RA). The patent is held by Novartis Pharmaceuticals. Novartis markets valsartan as Diovan. The patent expired in September 2012. Pfizer's patent on amlodipine expired in 2007. Until then, it was marketed as Norvasc.Exforge is available in different dose preparations: 5 mg/80 mg, 5 mg/160 mg, 10 mg/160 mg, 5 mg/320 mg and 10/320 mg of amlodipine and valsartan, respectively.Exforge is also available with hydrochlorothiazide under the brand name Exforge HCT, for patients who need a three drug regimen to manage their blood pressure.Cipla has just launched Amlopres VL in this combination.".
- Q4747075 atcPrefix "C09".
- Q4747075 atcSuffix "DB01".
- Q4747075 pubchem "11354874".
- Q4747075 thumbnail Amlodipine.svg?width=300.
- Q4747075 wikiPageExternalLink index.jsp?usertrack.filter_applied=true&NovaId=1178761800789058563.
- Q4747075 wikiPageWikiLink Q155472.
- Q4747075 wikiPageWikiLink Q285044.
- Q4747075 wikiPageWikiLink Q39094.
- Q4747075 wikiPageWikiLink Q411347.
- Q4747075 wikiPageWikiLink Q421700.
- Q4747075 wikiPageWikiLink Q431289.
- Q4747075 wikiPageWikiLink Q507154.
- Q4747075 wikiPageWikiLink Q575890.
- Q4747075 wikiPageWikiLink Q8252305.
- Q4747075 wikiPageWikiLink Q8918235.
- Q4747075 wikiPageWikiLink Q9536267.
- Q4747075 atcPrefix "9.0".
- Q4747075 atcSuffix "DB01".
- Q4747075 pubchem "11354874".
- Q4747075 type ChemicalSubstance.
- Q4747075 type Drug.
- Q4747075 type ChemicalObject.
- Q4747075 type Thing.
- Q4747075 type Q8386.
- Q4747075 comment "Exforge is the brand name of an oral blood pressure lowering medication which combines two medications in a film-coated tablet. It contains amlodipine, a dihydropyridine-type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist (ARB or A2RA). The patent is held by Novartis Pharmaceuticals. Novartis markets valsartan as Diovan. The patent expired in September 2012. Pfizer's patent on amlodipine expired in 2007.".
- Q4747075 label "Amlodipine/valsartan".
- Q4747075 depiction Amlodipine.svg.